Abstract
The medical information department within a pharmaceutical company functions to provide concise, consistent, and appropriate information and customer service to external and internal customers, while maintaining effective and quality-controlled processes. These medical information departmental goals become more challenging when two companies form a partnership, because of the complexity of additional staff members with varying goals and objectives involved in joint venture projects. The objective of this article is to review how two medical information groups function within a pharmaceutical alliance, and examine changes in the partnership that occurred in the different stages of the drug product life cycle. This is the first published article on the late-phase maintenance of a pharmaceutical alliance in medical information.
Get full access to this article
View all access options for this article.
